Institutional Ownership Rhythm Pharmaceuticals, Inc. (RYTM)
This table provides information about the institutional ownership of Rhythm Pharmaceuticals, Inc. (RYTM). We have compiled data on the 245 institutions that hold shares in the stock, with a total of 62.9 Million shares, which have been reported (via 13F filing form) to have a value of $4.02 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Opaleye Management Inc.
Boston, MA |
May 15, 2025 Q1 2025 |
490,000
shares
|
$31.3 Million
7.14% of portfolio
|
Q1 2025
Reduced 2.0%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
446,839
shares
|
$28.5 Million
1.74% of portfolio
|
Q1 2025
Added 12.43%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
445,429
shares
|
$28.4 Million
0.0% of portfolio
|
Q1 2025
Added 1.18%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
May 15, 2025 Q1 2025 |
422,868
shares
|
$27 Million
0.09% of portfolio
|
Q1 2025
Added 11.12%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
380,000
shares
|
$24.3 Million
0.63% of portfolio
|
Q1 2025
Reduced 5.0%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
355,712
shares
|
$22.7 Million
0.03% of portfolio
|
Q1 2025
Added 157.09%
|
|
|
Silverarc Capital Management, LLC
|
May 14, 2025 Q1 2025 |
337,605
shares
|
$21.6 Million
4.36% of portfolio
|
Q1 2025
Added 23.26%
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
326,160
shares
|
$20.8 Million
0.01% of portfolio
|
Q1 2025
Added 21.61%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
291,469
shares
|
$18.6 Million
0.1% of portfolio
|
Q1 2025
Reduced 12.31%
|
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
277,533
shares
|
$17.7 Million
0.84% of portfolio
|
Q1 2025
New holding
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
272,108
shares
|
$17.4 Million
0.0% of portfolio
|
Q1 2025
Added 7.02%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
261,902
shares
|
$16.7 Million
0.0% of portfolio
|
Q1 2025
Reduced 13.52%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
259,346
shares
|
$16.6 Million
0.02% of portfolio
|
Q1 2025
Reduced 30.91%
|
|
|
Comerica Bank
|
May 14, 2025 Q1 2025 |
244,754
shares
|
$15.6 Million
0.06% of portfolio
|
Q1 2025
Added 1330.22%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
217,379
shares
|
$13.9 Million
0.01% of portfolio
|
Q1 2025
Added 1324.6%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
216,193
shares
|
$13.8 Million
0.01% of portfolio
|
Q1 2025
Added 127.01%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
173,822
shares
|
$11.1 Million
0.06% of portfolio
|
Q1 2025
New holding
|
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2025 Q1 2025 |
150,000
shares
|
$9.58 Million
0.84% of portfolio
|
Q1 2025
Reduced 62.5%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
147,301
shares
|
$9.41 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
146,903
shares
|
$9.38 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.66%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
143,640
shares
|
$9.17 Million
0.0% of portfolio
|
Q1 2025
Reduced 45.71%
|
|
|
Panagora Asset Management Inc
Boston, MA |
May 15, 2025 Q1 2025 |
141,162
shares
|
$9.02 Million
0.04% of portfolio
|
Q1 2025
New holding
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
May 15, 2025 Q1 2025 |
138,118
shares
|
$8.82 Million
3.38% of portfolio
|
Q1 2025
Reduced 20.0%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
May 13, 2025 Q1 2025 |
135,360
shares
|
$8.65 Million
0.03% of portfolio
|
Q1 2025
Reduced 15.74%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
125,782
shares
|
$8.03 Million
0.0% of portfolio
|
Q1 2025
Reduced 42.45%
|